Comprehensive Analysis of N6-Methyladenosine RNA Methylation Regulators in the Diagnosis and Subtype Classification

Shaoxiong Zhang1, Shuo Sun1, Yajuan Zhang2

  • 1The 6th Affiliated Hospital of Kunming Medical University, Yuxi, Yunnan, China.

Biochemical Genetics
|December 19, 2023
PubMed

Insights

This study identifies key N6-methyladenosine (m6A) regulators involved in rheumatoid arthritis (RA) development. These m6A regulators can predict RA risk and classify patients, offering potential new therapeutic targets for RA.

Area of Science:

  • Epigenetics
  • Immunology
  • Molecular Biology

Background:

  • N6-methyladenosine (m6A) modification is a prevalent mRNA modification crucial for eukaryotic biological processes.
  • The specific role of m6A regulators in rheumatoid arthritis (RA) pathogenesis is not well understood.

Purpose of the Study:

  • To investigate the expression patterns of m6A RNA methylation regulators in RA.
  • To evaluate the functional and prognostic significance of these regulators in RA.
  • To develop a predictive model for RA risk based on m6A regulators.

Main Methods:

  • Differential gene expression analysis of the GSE93272 dataset to identify m6A regulators in RA patients.
  • Machine learning models (random forest, lasso regression) for screening key m6A regulators.
  • In vitro qPCR validation, nomogram construction, immuno-infiltration analysis, and consensus clustering.

Main Results:

  • Fifteen m6A regulators were identified, with five selected for risk prediction.
  • A nomogram model incorporating ELAVL1, WTAP, YTHDF1, and ALKBH5 demonstrated predictive utility.
  • Consensus clustering revealed two distinct m6A-based patient subgroups (ClusterA and ClusterB) with differential immune cell infiltration.
  • High ELAVL1 expression correlated with ClusterA immune infiltration patterns.

Conclusions:

  • m6A regulators play a significant role in the development and progression of rheumatoid arthritis.
  • m6A modification patterns represent a promising area for future RA therapeutic strategies.
  • The developed nomogram model shows potential clinical benefit for RA patients.